A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?

Conflicting evidence exists about the effect of angiotensin‐converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) on COVID‐19 clinical outcomes. We aimed to provide a comprehensive/updated evaluation of the effect of ACEIs/ARBs on COVID‐19‐related clinical outcomes, including exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurdi, Amanj, Abutheraa, Nouf, Akil, Lina, Godman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575889/
https://www.ncbi.nlm.nih.gov/pubmed/33084232
http://dx.doi.org/10.1002/prp2.666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575889/
https://www.ncbi.nlm.nih.gov/pubmed/33084232
http://dx.doi.org/10.1002/prp2.666

Ejemplares similares